These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24216080)

  • 1. Anemia and iron deficiency in heart failure.
    Gil VM; Ferreira JS
    Rev Port Cardiol; 2014 Jan; 33(1):39-44. PubMed ID: 24216080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Consensus document on anemia and iron deficiency in heart failure: Consejo Interamericano de Falla Cardiaca e Hipertensión Pulmonar (CIFACAH) of the Interamerican Society of Cardiology (IASC).
    Speranza M; Gómez-Mesa JE; Fairman E; Rossel V; Fernández FN; Saldarriaga C; Pow-Chon F; Quesada D; Ramos CE; Rodríguez I; Jerez A; Chávez A; Núñez E; Pereda M; Chazzin G; Sosa-Liprandi MI; Romero A
    Arch Cardiol Mex; 2023; 93(Supl):27-38. PubMed ID: 37918407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Settling the IRONy of Anemia in Heart Failure: Current Evidence and Future Directions.
    Tsangaris A; Ambrosy AP; Tschida M; Alexy T
    J Card Fail; 2024 May; 30(5):691-693. PubMed ID: 38401670
    [No Abstract]   [Full Text] [Related]  

  • 4. [How I explore… anemia in children].
    Hindryckx É; Chantrain C
    Rev Med Liege; 2024 Mar; 79(3):181-185. PubMed ID: 38487913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in heart failure management.
    Zamorano JL; González Leal A
    Med Clin (Barc); 2024 Jul; 163(1):32-39. PubMed ID: 38418309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treating Iron Deficiency in Heart Failure.
    Martens P; Mullens W
    N Engl J Med; 2023 Sep; 389(11):1041-1042. PubMed ID: 37632465
    [No Abstract]   [Full Text] [Related]  

  • 7. Iron therapy for patients with iron deficiency and heart failure: a treatment strategy that is increasingly opaque.
    Thankachen J; Hall S; Alam A
    Proc (Bayl Univ Med Cent); 2024; 37(3):477-478. PubMed ID: 38628330
    [No Abstract]   [Full Text] [Related]  

  • 8. Iron deficiency in heart failure: why so frequent and which mechanisms?
    Cohen-Solal A
    Eur Heart J; 2022 Feb; 43(7):e35-e37. PubMed ID: 31860068
    [No Abstract]   [Full Text] [Related]  

  • 9. [Not Available].
    Grätzel von Grätz P
    MMW Fortschr Med; 2023 Oct; 165(18):18-19. PubMed ID: 37828310
    [No Abstract]   [Full Text] [Related]  

  • 10. Improving investigation for iron deficiency in patients with heart failure on the cardiology ward.
    Al-Hadithi A; Hurley P; Cacciottolo P
    Future Healthc J; 2023 Nov; 10(Suppl 3):99-100. PubMed ID: 38406745
    [No Abstract]   [Full Text] [Related]  

  • 11. Anemia Status as a Novel Biomarker of Risk of Heart Failure in Patients With Coronary Heart Disease.
    Li Y; Qiu JZ
    Angiology; 2023 Sep; ():33197231201709. PubMed ID: 37682535
    [No Abstract]   [Full Text] [Related]  

  • 12. Anemia and iron deficiency in heart failure.
    Arora NP; Ghali JK
    Heart Fail Clin; 2014 Apr; 10(2):281-94. PubMed ID: 24656105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The 2014 Canadian Cardiovascular Society Heart Failure Management Guidelines Focus Update: anemia, biomarkers, and recent therapeutic trial implications.
    Moe GW; Ezekowitz JA; O'Meara E; Lepage S; Howlett JG; Fremes S; Al-Hesayen A; Heckman GA; Abrams H; Ducharme A; Estrella-Holder E; Grzeslo A; Harkness K; Koshman SL; McDonald M; McKelvie R; Rajda M; Rao V; Swiggum E; Virani S; Zieroth S; Arnold JM; Ashton T; D'Astous M; Chan M; De S; Dorian P; Giannetti N; Haddad H; Isaac DL; Kouz S; Leblanc MH; Liu P; Ross HJ; Sussex B; White M;
    Can J Cardiol; 2015 Jan; 31(1):3-16. PubMed ID: 25532421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SWOG S0800 (NCI CDR0000636131): addition of bevacizumab to neoadjuvant nab-paclitaxel with dose-dense doxorubicin and cyclophosphamide improves pathologic complete response (pCR) rates in inflammatory or locally advanced breast cancer.
    Nahleh ZA; Barlow WE; Hayes DF; Schott AF; Gralow JR; Sikov WM; Perez EA; Chennuru S; Mirshahidi HR; Corso SW; Lew DL; Pusztai L; Livingston RB; Hortobagyi GN
    Breast Cancer Res Treat; 2016 Aug; 158(3):485-95. PubMed ID: 27393622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoadjuvant Bevacizumab plus Chemotherapy versus Chemotherapy Alone to Treat Non-Metastatic Breast Cancer: A Meta-Analysis of Randomised Controlled Trials.
    Cao L; Yao GY; Liu MF; Chen LJ; Hu XL; Ye CS
    PLoS One; 2015; 10(12):e0145442. PubMed ID: 26717149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PI3K/mTOR dual inhibitor VS-5584 preferentially targets cancer stem cells.
    Kolev VN; Wright QG; Vidal CM; Ring JE; Shapiro IM; Ricono J; Weaver DT; Padval MV; Pachter JA; Xu Q
    Cancer Res; 2015 Jan; 75(2):446-55. PubMed ID: 25432176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency†.
    Ponikowski P; van Veldhuisen DJ; Comin-Colet J; Ertl G; Komajda M; Mareev V; McDonagh T; Parkhomenko A; Tavazzi L; Levesque V; Mori C; Roubert B; Filippatos G; Ruschitzka F; Anker SD;
    Eur Heart J; 2015 Mar; 36(11):657-68. PubMed ID: 25176939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iron deficiency: an emerging therapeutic target in heart failure.
    Cohen-Solal A; Leclercq C; Deray G; Lasocki S; Zambrowski JJ; Mebazaa A; de Groote P; Damy T; Galinier M
    Heart; 2014 Sep; 100(18):1414-20. PubMed ID: 24957529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Everolimus for women with trastuzumab-resistant, HER2-positive, advanced breast cancer (BOLERO-3): a randomised, double-blind, placebo-controlled phase 3 trial.
    André F; O'Regan R; Ozguroglu M; Toi M; Xu B; Jerusalem G; Masuda N; Wilks S; Arena F; Isaacs C; Yap YS; Papai Z; Lang I; Armstrong A; Lerzo G; White M; Shen K; Litton J; Chen D; Zhang Y; Ali S; Taran T; Gianni L
    Lancet Oncol; 2014 May; 15(6):580-91. PubMed ID: 24742739
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?
    McDonagh T; Macdougall IC
    Eur J Heart Fail; 2015 Mar; 17(3):248-62. PubMed ID: 25639592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.